Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 172

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 172

Pharmaceutical Technology

APRIL 19, 2023

“If approved, roflumilast foam would be the first topical drug with a new mechanism of action for this condition in over two decades, highlighting the unique formulation and deep dermatological expertise that Arcutis brings to immuno-dermatology.” in patients with seborrheic dermatitis.

Dermatology 130

Dermatology Trials Drugs Regulation 130

XTalks

APRIL 17, 2023

These results are very promising for patients with atopic dermatitis,” said Jonathan Silverberg, MD, professor of dermatology at George Washington University School of Medicine & Health Sciences and co-investigator of the studies, in the company’s press release.

Dermatology 97

Dermatology Antibody Clinical Trials Clinical Trials 97

The Pharma Data

OCTOBER 29, 2020

Data support baricitinib’s ongoing Phase 3 program and potential to be the first approved medicine for people living with alopecia areata (AA). . The data underscore Lilly’s commitment to providing medicines for dermatologic diseases that have high unmet need, including alopecia areata (AA). INDIANAPOLIS , Oct.

Dermatology 52

Dermatology Development Medicine Clinical Trials 52

XTalks

AUGUST 2, 2023

Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases that require medical interventions. Tune into this episode to learn more about YCANTH and its approval, as well as the changing landscape of dermatology, from Dr. Eichenfield.

Life Science 52

Life Science FDA Approval Dermatology Pharmacy 52

FDA Law Blog

NOVEMBER 10, 2024

These have included clinical trials for rare diseases across metabolic (n=5), oncology (n=5), cardiology (n=3), dermatology (n=3), pulmonary (n=3), hematology (n=2), hepatology (n=2), ocular (n=2), transplant (n=1), gastrointestinal (n=1), immunology (n=1), infectious (n=1), neurology (n=1), orthopedic (n=1), and toxicology (n=1) indications.

Production 69

Production Clinical Development Development Regulation 69

STAT News

DECEMBER 2, 2022

Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Dermatology 98

XTalks

MAY 26, 2023

Results of the trials are published in the journals Nature Medicine and The New England Journal of Medicine. Peter Marinkovich, primary investigator of the GEM-3 trial, director of the Blistering Disease Clinic at Stanford Health Care and associate professor of dermatology at the Stanford University School of Medicine.

Gene Therapy 97

Gene Therapy Gene FDA Approval Dermatology 97

Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Its investigational medicinal products comprise R-107, R-131 and R-147. Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Its investigational medicinal products comprise R-107, R-131 and R-147. Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

The Pharma Data

OCTOBER 1, 2021

The research, which spans clinical, health economics and outcomes research, translational, clinical pharmacology and preclinical presentations, highlights the breadth and depth of the company’s data on deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor, also because the emerging dermatology pipeline.

Dermatology 52

Dermatology Trials Research Clinical Development 52

Rethinking Clinical Trials

SEPTEMBER 24, 2024

Mirza, MD, MPH Chief Resident Department of Dermatology Warren Alpert Medical School of Brown University Slides Keywords Artificial Intelligence; ChatGPT; Informed Consent Key Points Artificial Intelligence (AI), when implemented thoughtfully in clinical settings, can lead to meaningful results for patients.

Clinical Trials 100

Clinical Trials Clinical Trials Dermatology Trials 100

Scienmag

OCTOBER 19, 2020

One third of the cytotoxic killer cells in the liver as a potential therapeutic target Credit: MedUni Wien/Matern (Vienna, 19 October 2020) Good news for the human immune system: researchers from MedUni Vienna’s Departments of Dermatology and Surgery have managed to ascribe an immunological memory function to a subset of cytotoxic NK cells, which (..)

Dermatology 61

Dermatology Research Allergies Medicine 61

The Pharma Data

JUNE 2, 2023

Zouboulis, President of the European Hidradenitis Suppurativa Foundation, Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Städtisches Klinikum Dessau, and Founding Professor of Dermatology and Venereology at the Brandenburg Medical School, Germany.

Dermatology 52

Dermatology Medicine Production Marketing 52

Scienmag

OCTOBER 28, 2020

Analysis of the largest registry of COVID-19 patients with dermatological symptoms has revealed a subset of patients, called ‘long-haulers’ or ‘long […].

Dermatology 54

Dermatology Medicine 54

The Pharma Data

NOVEMBER 29, 2021

Food and Drug Administration assigned a target action date of September 10, 2022; European Medicines Agency validation confirms the submission is complete and begins the centralized review process. The FDA has assigned a Tradition Medicine Stoner Figure Act (PDUFA) thing date of September 10, 2022.

Medicine 52

Medicine Drugs Dermatology Trials 52

Scienmag

JULY 7, 2021

Johns Hopkins Medicine study uncovers enzyme inhibitor that boosts immune system to fight MRSA and other dangerous skin infections Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health FOR IMMEDIATE RELEASE In what turned out to be one of the most important accidents of all time, Scottish bacteriologist Alexander (..)

Bacteria 97

Bacteria Allergies Medicine Dermatology 97

Scienmag

FEBRUARY 12, 2021

Acne treatment requires multidisciplinary approach, researchers say A more aggressive approach to treating acne that marries the disciplines of psychology and dermatology is needed, according to two UC Riverside psychology researchers. “Acne is pervasive, physically harmless, and painless, so […].

Dermatology 56

Dermatology Research Medicine 56

pharmaphorum

SEPTEMBER 8, 2022

The Digital Medicine Society (DiME) is today releasing a new set of open-access resources to advance the use of nocturnal scratch in the treatment of atopic dermatitis (AD). . It is hoped today’s event will serve as a “blueprint for the broader development and deployment of digital endpoints in medical product development”.

Dermatology 52

Dermatology Production Radiology Development 52

pharmaphorum

FEBRUARY 3, 2021

He also spent three years before that as Teva’s head of speciality medicines for Europe, and held previous senior roles at AstraZeneca, GSK and Eli Lilly. “Mr For the last three years he has served as executive vice president, growth markets commercial, at Israeli pharma Teva.

Dermatology 52

Dermatology Marketing Branding Medicine 52

Scienmag

JANUARY 25, 2021

Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments WASHINGTON (Jan.

Dermatology 40

Dermatology Research Medicine 40

XTalks

DECEMBER 15, 2020

Related: An Integrated Development Plan in Rare & Orphan Medicinal Products – Accelerating Time to Approval and Strengthening Asset Value. Synteract has a solid reputation in the emerging biopharma sphere, providing therapeutic expertise in areas including oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics.

Dermatology 98

Dermatology Clinical Trials Clinical Trials Branding 98

Pharmaceutical Technology

APRIL 13, 2023

For some therapy areas, such as dermatology, recent improvements in remote video capture quality allows more accurate virtual assessments, and analysis shows [6] that nearly 24% of dermatology DCTs now incorporate this virtual component.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Dermatology 130

XTalks

MAY 23, 2024

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. In fact, tools such as dermatoscopes, digital imaging systems and artificial intelligence (AI)-powered diagnostic tools have become integral to dermatological practice.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

Scienmag

OCTOBER 28, 2020

The findings, presented at the 29th Congress of the European Academy of Dermatology and Venereology by investigators at Massachusetts […]. BOSTON – Some patients with COVID-19 have persistent skin-related symptoms long after their initial infection has cleared, according to a new analysis.

Dermatology 44

Dermatology Research Medicine 44

Pharmaceutical Technology

FEBRUARY 18, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Antibody Development 100

Scienmag

DECEMBER 7, 2020

In a recent study published in the British Journal of Dermatology, individuals with atopic dermatitis, or eczema, were more likely to also have various autoimmune diseases, especially those involving the skin, the gastrointestinal tract, or the connective tissue.

Dermatology 42

Dermatology Research Allergies Medicine 42

pharmaphorum

AUGUST 28, 2020

Shares in dermatology specialist Cassiopea, which is listed on the SWX exchange in Switzerland, rose almost 17% after news of the FDA approval emerged. The biotech isn’t revealing how much it intends to charge for the new medicine, saying it will do so closer to launch later this year.

Dermatology 52

Dermatology Drugs Hormones FDA Approval 52

Scienmag

OCTOBER 23, 2020

Brand showcases proven power of nature-based regimens across lip health and anti-aging categories at virtual Integrative Dermatology Symposium 2020 DURHAM, N.C.,

Dermatology 41

Dermatology Branding Research Medicine 41

The Pharma Data

NOVEMBER 13, 2020

Long, from the Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues examined the training backgrounds and scope of practice of American Board of Cosmetic Surgery (ABCS)-certified physicians. percent), dermatology (51.6 FRIDAY, Nov. The researchers found that among 342 ABCS-certified physicians, 212 (60.2

Cosmetics 52

Cosmetics Dermatology Medicine Research 52

Scienmag

MAY 6, 2021

More than two-thirds of the public may now have hand dermatitis due to stringent hand washing and using alcohol-based rubs during the COVID-19 pandemic LUGANO, 6 May, 2021- The dermatological impact of COVID-19 is a burning topic at EADV’s 2021 Spring Symposium.

Dermatology 40

Dermatology Research Medicine 40

Scienmag

MAY 21, 2021

UC San Diego School of Medicine researchers identify how the body regulates and prevents constant skin inflammation The human body is constantly exposed to various environmental actors, from viruses to bacteria to fungi, but most of these microbial organisms provoke little or no response from our skin, which is charged with monitoring and protecting (..)

Bacteria 75

Bacteria Regulation Medicine Research 75

The Pharma Data

MAY 1, 2023

. “The fluctuating symptoms and unpredictable nature of atopic dermatitis, along with limited medicines that can adequately manage long-term uncontrolled symptoms, represent major challenges in the treatment of this chronic disease,” said Jenny Murase, M.D., P-LLY Source link: [link]

Dermatology 40

Dermatology Medicine Clinical Trials Clinical Trials 40

The Pharma Data

MARCH 27, 2022

More than 50 percent of patients with moderate-to-severe atopic dermatitis (AD) experienced at least 75 percent reduction in disease severity (EASI-75*) at 16 weeks when receiving lebrikizumab monotherapy in the ADvocate program, Eli Lilly and Company (NYSE: LLY) announced today at the American Academy of Dermatology (AAD) Annual Meeting.

Dermatology 52

Dermatology Medicine Antibody Protein 52